These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15033950)

  • 1. Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women.
    Molskness TA; Stouffer RL; Burry KA; Gorrill MJ; Lee DM; Patton PE
    Hum Reprod; 2004 Apr; 19(4):822-30. PubMed ID: 15033950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
    Pau E; Alonso-Muriel I; Gómez R; Novella E; Ruiz A; García-Velasco JA; Simón C; Pellicer A
    Hum Reprod; 2006 Jun; 21(6):1453-60. PubMed ID: 16488907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A.
    Pietrowski D; Szabo L; Sator M; Just A; Egarter C
    Hum Reprod; 2012 Jan; 27(1):196-9. PubMed ID: 22016416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome.
    Tozer AJ; Iles RK; Iammarrone E; Gillott CM; Al-Shawaf T; Grudzinskas JG
    Hum Reprod; 2004 Mar; 19(3):522-8. PubMed ID: 14998945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF.
    Manau D; Fábregues F; Peñarrubia J; Creus M; Carmona F; Casals G; Jiménez W; Balasch J
    Hum Reprod; 2007 Mar; 22(3):669-75. PubMed ID: 17079244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
    Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
    Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
    Melanoma Res; 2006 Oct; 16(5):405-11. PubMed ID: 17013089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine gland-derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome in women undergoing controlled ovarian hyperstimulation.
    Gao MZ; Zhao XM; Sun ZG; Hong Y; Zhao LW; Zhang HQ
    Fertil Steril; 2011 Feb; 95(2):673-8. PubMed ID: 21067720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF, IVF clinical variables and ovarian hyperstimulation syndrome: a prospective study of the preimplantation luteal phase.
    Kung FT; Chang SY; Huang FJ; Lan KC
    J Reprod Med; 2007 May; 52(5):365-74. PubMed ID: 17583233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Predictive Role of Vascular Endothelial Growth Factor and Estradiol in Infertile Patients with Ovarian Hyperstimulation Syndrome].
    Wang Q; Yang G; Yang C; Zhan B; Yang R
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):565-7. PubMed ID: 12910723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble receptors for vascular endothelial growth factor (sVEGFR1/sVEGFR2) in infantile hemangioma.
    Przewratil P; Sitkiewicz A; Andrzejewska E
    Growth Factors; 2010 Dec; 28(6):417-25. PubMed ID: 20854187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF.
    Artini PG; Ruggiero M; Parisen Toldin MR; Monteleone P; Monti M; Cela V; Genazzani AR
    Hum Fertil (Camb); 2009 Mar; 12(1):40-4. PubMed ID: 19330612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome.
    Kosaka K; Fujiwara H; Yoshioka S; Fujii S
    Hum Reprod; 2007 Jun; 22(6):1647-51. PubMed ID: 17356124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome?
    Geva E; Amit A; Lessing JB; Lerner-Geva L; Daniel Y; Yovel I; Azem F; Barak V
    J Reprod Med; 1999 Feb; 44(2):91-6. PubMed ID: 10853438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.
    Villasante A; Pacheco A; Pau E; Ruiz A; Pellicer A; Garcia-Velasco JA
    Hum Reprod; 2008 Mar; 23(3):662-7. PubMed ID: 18216038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiology and pathology of ovarian hyperstimulation syndrome.
    Gómez R; Soares SR; Busso C; Garcia-Velasco JA; Simón C; Pellicer A
    Semin Reprod Med; 2010 Nov; 28(6):448-57. PubMed ID: 21082502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Function of vascular endothelial growth factor in ovarian hyperstimulation syndrome].
    Liang W; Chen S; Xing F
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):651-3. PubMed ID: 11930687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of vascular endothelial growth factor and its receptors in patients with severe autism.
    Emanuele E; Orsi P; Barale F; di Nemi SU; Bertona M; Politi P
    Clin Biochem; 2010 Feb; 43(3):317-9. PubMed ID: 19850021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating angiogenic factors during periovulation and the luteal phase of normal menstrual cycles.
    Malamitsi-Puchner A; Sarandakou A; Tziotis J; Stavreus-Evers A; Tzonou A; Landgren BM
    Fertil Steril; 2004 May; 81(5):1322-7. PubMed ID: 15136097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between circulating vascular endothelial growth factor and its soluble receptors in adults with dengue virus infection: a case-control study.
    Seet RC; Chow AW; Quek AM; Chan YH; Lim EC
    Int J Infect Dis; 2009 Sep; 13(5):e248-53. PubMed ID: 19261502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.